- Home
- VYNE vs HHS Comparison
VYNE vs HHS Comparison
Compare VYNE & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- HHS
- Stock Information
- Founded
- VYNE 2003
- HHS 1923
- Country
- VYNE United States
- HHS United States
- Employees
- VYNE N/A
- HHS N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- VYNE Health Care
- HHS Consumer Discretionary
- Exchange
- VYNE Nasdaq
- HHS Nasdaq
- Market Cap
- VYNE 24.3M
- HHS 28.4M
- IPO Year
- VYNE 2018
- HHS N/A
- Fundamental
- Price
- VYNE $0.35
- HHS $3.69
- Analyst Decision
- VYNE Buy
- HHS
- Analyst Count
- VYNE 2
- HHS 0
- Target Price
- VYNE $8.00
- HHS N/A
- AVG Volume (30 Days)
- VYNE 4.1M
- HHS 5.3K
- Earning Date
- VYNE 08-14-2025
- HHS 08-07-2025
- Dividend Yield
- VYNE N/A
- HHS N/A
- EPS Growth
- VYNE N/A
- HHS N/A
- EPS
- VYNE N/A
- HHS N/A
- Revenue
- VYNE $476,000.00
- HHS $174,951,000.00
- Revenue This Year
- VYNE $42.51
- HHS $6.54
- Revenue Next Year
- VYNE N/A
- HHS N/A
- P/E Ratio
- VYNE N/A
- HHS N/A
- Revenue Growth
- VYNE N/A
- HHS N/A
- 52 Week Low
- VYNE $0.33
- HHS $3.06
- 52 Week High
- VYNE $4.30
- HHS $7.72
- Technical
- Relative Strength Index (RSI)
- VYNE 29.46
- HHS 55.34
- Support Level
- VYNE $0.35
- HHS $3.51
- Resistance Level
- VYNE $0.36
- HHS $3.86
- Average True Range (ATR)
- VYNE 0.04
- HHS 0.09
- MACD
- VYNE -0.02
- HHS 0.05
- Stochastic Oscillator
- VYNE 1.79
- HHS 69.30
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.